SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] NTN 10K: (Original Filing)
[]
SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 25-NSE: (Original Filing)
[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;} .FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;} .FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: right;} .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif;} .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif;} .FormNumText {font-size: small; font-weight: bold; font-family:]
SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 25-NSE: .FormData {color: blue; background-color: white; font-size: small; font-family:
[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;} .FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;} .FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: right;} .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif;} .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif;} .FormNumText {font-size: small; font-weight: bold; font-family:]
SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] SC 13G/A: (Original Filing)
[reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities that]
SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] SC 13G/A: reporting person’s initial filing on this form with
[reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities that]
SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: (Original Filing)
[SKYSTAR BIO-PHARMACEUTICAL COMPANY ANNOUNCES DELISTING FROM NASDAQ Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI), a China-based manufacturer and distributor of veterinary medicine, vaccines, micro-organisms and feed additives, announced that on December 17, 2015, Skystar Bio-Pharmaceutical Company (the “Company”) received notification from The Nasdaq Stock Market (“Nasdaq”) informing the Company that a Nasdaq hearing panel had decided to delist the Company’s shares from] []
SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: SKYSTAR BIO-PHARMACEUTICAL COMPANY ANNOUNCES DELISTING FROM NASDAQ Skystar
[SKYSTAR BIO-PHARMACEUTICAL COMPANY ANNOUNCES DELISTING FROM NASDAQ Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI), a China-based manufacturer and distributor of veterinary medicine, vaccines, micro-organisms and feed additives, announced that on December 17, 2015, Skystar Bio-Pharmaceutical Company (the “Company”) received notification from The Nasdaq Stock Market (“Nasdaq”) informing the Company that a Nasdaq hearing panel had decided to delist the Company’s shares from] []
